Cite
Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial).
MLA
Hendriks, Pim, et al. “Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial).” CardioVascular & Interventional Radiology, vol. 45, no. 8, Aug. 2022, pp. 1057–63. EBSCOhost, https://doi.org/10.1007/s00270-022-03162-7.
APA
Hendriks, P., Rietbergen, D. D. D., van Erkel, A. R., Coenraad, M. J., Arntz, M. J., Bennink, R. J., Braat, A. E., Crobach, A. S. L. P., van Delden, O. M., van der Hulle, T., Klümpen, H.-J., van der Meer, R. W., Nijsen, J. F. W., van Rijswijk, C. S. P., Roosen, J., Ruijter, B. N., Smit, F., Stam, M. K., Takkenberg, R. B., & Tushuizen, M. E. (2022). Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial). CardioVascular & Interventional Radiology, 45(8), 1057–1063. https://doi.org/10.1007/s00270-022-03162-7
Chicago
Hendriks, Pim, Daphne D. D. Rietbergen, Arian R. van Erkel, Minneke J. Coenraad, Mark J. Arntz, Roel J. Bennink, Andries E. Braat, et al. 2022. “Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial).” CardioVascular & Interventional Radiology 45 (8): 1057–63. doi:10.1007/s00270-022-03162-7.